DOI QR코드

DOI QR Code

일산화탄소 중독 환자에서 고유속 비강 캐뉼라 산소치료 효과에 대한 예비 연구

A Preliminary Study for Effect of High Flow Oxygen through Nasal Cannula Therapy in Carbon Monoxide Poisoning

  • 김영민 (충북대학교 의과대학 충북대학교병원 응급의학과) ;
  • 김상철 (충북대학교 의과대학 충북대학교병원 응급의학과) ;
  • 박관진 (충북대학교 의과대학 충북대학교병원 응급의학과) ;
  • 이석우 (충북대학교 의과대학 충북대학교병원 응급의학과) ;
  • 이지한 (충북대학교 의과대학 충북대학교병원 응급의학과) ;
  • 김훈 (충북대학교 의과대학 충북대학교병원 응급의학과)
  • Kim, Young-Min (Department of Emergency Medicine, Chungbuk National University, School of Medicine, Chungbuk National University Hospital) ;
  • Kim, Sang-Chul (Department of Emergency Medicine, Chungbuk National University, School of Medicine, Chungbuk National University Hospital) ;
  • Park, Kwan-Jin (Department of Emergency Medicine, Chungbuk National University, School of Medicine, Chungbuk National University Hospital) ;
  • Lee, Seok-Woo (Department of Emergency Medicine, Chungbuk National University, School of Medicine, Chungbuk National University Hospital) ;
  • Lee, Ji-Han (Department of Emergency Medicine, Chungbuk National University, School of Medicine, Chungbuk National University Hospital) ;
  • Kim, Hoon (Department of Emergency Medicine, Chungbuk National University, School of Medicine, Chungbuk National University Hospital)
  • 투고 : 2019.06.28
  • 심사 : 2019.07.30
  • 발행 : 2019.12.31

초록

Purpose: Acute carbon monoxide (CO) poisoning is one of the most common types of poisoning and a major health problem worldwide. Treatment options are limited to normobaric oxygen therapy, administered using a non-rebreather face mask or hyperbaric oxygen. Compared to conventional oxygen therapy, high-flow nasal cannula oxygen (HFNC) creates a positive pressure effect through high-flow rates. The purpose of this human pilot study is to determine the effects of HFNC on the rate of CO clearance from the blood, in patients with mild to moderate CO poisoning. Methods: CO-poisoned patients were administered 100% oxygen from HFNC (flow of 60 L/min). The fraction of COHb (fCOHb) was measured at 30-min intervals until it decreased to under 10%, and the half-life time of fCOHb (fCOHb t1/2) was subsequently determined. Results: At the time of ED arrival, a total of 10 patients had fCOHb levels ≥10%, with 4 patients ranging between 10% and 50%. The mean rate of fCOHb elimination patterns exhibits logarithmic growth curves that initially increase quickly with time (HFNC equation, Y=0.3388*X+11.67). The mean fCOHbt1/2 in the HFNC group was determined to be 48.5±12.4 minutes. Conclusion: In patients with mild to moderate CO poisoning, oxygen delivered via high flow nasal cannula is a safe and comfortable method to treat acute CO toxicity, and is effective in reducing the COHb half-life. Our results indicate HFNC to be a promising alternative method of delivering oxygen for CO toxicity. Validating the effectiveness of this method will require larger studies with clinical outcomes.

키워드

참고문헌

  1. Rose JJ, Wang L, Xu Q, et al. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. Am J Respir Crit Care Med 2017;195:596-606. https://doi.org/10.1164/rccm.201606-1275CI
  2. Broome JR, Sykes JJ, Francis TJ, et al. Hyperbaric oxygen for carbon monoxide poisoning. Lancet 1989;2:1529.
  3. Garg J, Krishnamoorthy P, Palaniswamy C, et al. Cardiovascular Abnormalities in Carbon Monoxide Poisoning. Am J Ther 2018;25:e339-e48. https://doi.org/10.1097/MJT.0000000000000016
  4. Lin MS, Lin CC, Yang CC, et al. Myocardial injury was associated with neurological sequelae of acute carbon monoxide poisoning in Taiwan. J Chin Med Assoc 2018;81:682-90. https://doi.org/10.1016/j.jcma.2017.12.006
  5. Satran D, Henry CR, Adkinson C, et al. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 2005;45:1513-6. https://doi.org/10.1016/j.jacc.2005.01.044
  6. Oh S, Choi SC. Acute carbon monoxide poisoning and delayed neurological sequelae: a potential neuroprotection bundle therapy. Neural Regen Res 2015;10:36-8. https://doi.org/10.4103/1673-5374.150644
  7. Peters SG, Holets SR, Gay PC. High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir Care 2013;58:597-600. https://doi.org/10.4187/respcare.01887
  8. Carratala Perales JM, Llorens P, Brouzet B, et al. High-Flow therapy via nasal cannula in acute heart failure. Rev Esp Cardiol 2011;64:723-5. https://doi.org/10.1016/j.rec.2010.10.035
  9. Ciuffini F, Colnaghi M, Lavizzari A, et al. [Therapy with high-flow nasal prongs in preterm infants]. Pediatr Med Chir 2013;35:118-24.
  10. Marjanovic N, Mace J, Thille AW, et al. Reply to Understanding the benefits of early high-flow nasal cannula for adults with acute hypoxemic respiratory failure in the ED. Am J Emerg Med 2019;37:159-64. https://doi.org/10.1016/j.ajem.2018.05.022
  11. Weaver LK, Howe S, Hopkins R, et al. Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest. 2000;117:801-8. https://doi.org/10.1378/chest.117.3.801
  12. Kao LW, Nanagas KA. Carbon monoxide poisoning. Emerg Med Clin North Am 2004;22:985-1018. https://doi.org/10.1016/j.emc.2004.05.003
  13. Burney RE, Wu SC, Nemiroff MJ. Mass carbon monoxide poisoning: clinical effects and results of treatment in 184 victims. Ann Emerg Med 1982;11:394-9. https://doi.org/10.1016/S0196-0644(82)80033-4
  14. Jay GD, Tetz DJ, Hartigan CF, et al. Portable hyperbaric oxygen therapy in the emergency department with the modified Gamow bag. Ann Emerg Med 1995;26:707-11. https://doi.org/10.1016/S0196-0644(95)70042-0
  15. Li CK, Tsui KL, Hung CY, et al. A retrospective study on carboxyhaemoglobin half-life in acute carbon monoxide poisoning in patients treated with normobaric high flow oxygen levels. Hong Kong Journal of emergency medicine 2006;13:205-11. https://doi.org/10.1177/102490790601300403
  16. Hampson NB, Little CE. Hyperbaric treatment of patients with carbon monoxide poisoning in the United States. Undersea Hyperb Med 2005;32:21-6.
  17. Kim EJ, Jung CY, Kim KC. Effectiveness and Safety of High-Flow Nasal Cannula Oxygen Delivery during Bronchoalveolar Lavage in Acute Respiratory Failure Patients. Tuberc Respir Dis (Seoul) 2018;81:319-29. https://doi.org/10.4046/trd.2017.0122
  18. Sharma S, Chakraborty RK. High Flow Nasal Cannula, StatPearls, Ed. Treasure Island (FL); 2019.
  19. Sotello D, Rivas M, Mulkey Z, et al. High-flow nasal cannula oxygen in adult patients: a narrative review. Am J Med Sci 2015;349:179-85. https://doi.org/10.1097/MAJ.0000000000000345